Thus, it is possible that (E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol inhibits colon cancer cell growth via inhibition of both STAT3 and NF-κB pathways. Here, STAT3 is linked to malignant colon neoplasm.